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The C terminus of the herpes simplex virus type 1 origin-
binding protein, UL9ct, interacts directly with the viral single-
stranded DNA-binding protein ICP8.We show that a 60-amino
acid C-terminal deletion mutant of ICP8 (ICP8C) also binds
very strongly to UL9ct. Using small angle x-ray scattering, the
low resolution solution structures of UL9ct alone, in complex
with ICP8C, and in complex with a 15-mer double-stranded
DNA containing Box I of the origin of replication are described.
Size exclusion chromatography, analytical ultracentrifugation,
and electrophoretic mobility shift assays, backed up by isother-
mal titration calorimetry measurements, are used to show that
the stoichiometry of the UL9ct-dsDNA15-mer complex is 2:1 at
micromolar protein concentrations. The reaction occurs in two
steps with initial binding of UL9ct to DNA (Kd  6 nM) followed
by a second binding event (Kd  0.8 nM). It is also shown that the
stoichiometry of the ternaryUL9ct-ICP8C-dsDNA15-mer com-
plex is 2:1:1, at the concentrations used in the different assays.
Electron microscopy indicates that the complex assembled on
the extended origin, oriS, rather than Box I alone, is much
larger. The results are consistent with a simplemodel whereby a
conformational switch of the UL9 DNA-binding domain upon
binding to Box I allows the recruitment of a UL9-ICP8 complex
by interaction between the UL9 DNA-binding domains.
The initiation of DNA replication for most double-stranded
DNA (dsDNA)6 viral genomes begins with the recognition of
the origin by specific origin-binding proteins. The herpes sim-
plex virus type 1 (HSV-1) genome encodes seven proteins
required for origin-dependent DNA replication. These are the
DNA polymerase (UL30) and its accessory protein (UL42), a
heterotrimeric helicase-primase complex (UL5, UL8, and
UL52), the single-stranded DNA-binding protein (ICP8 or
UL29), and the origin-binding protein (UL9) (reviewed in Ref.
1).HSV-1 contains three functional origins, oriL and two copies
of oriS. OriS, which is about 80 bp in length, consists of three
UL9 recognition sites, in Boxes I, II, and III, which are arranged
in two overlapping palindromes (2). Box I andBox III are part of
an evolutionarily conserved palindrome that forms a stable
hairpin in single-strandedDNA,whichmay be important in the
origin rearrangement (3) during initiation of replication. Box I
and II are separated by an AT-rich spacer sequence, which var-
ies in length and nucleotide composition between the different
members of the -herpesvirus subfamily (2, 4–6).
UL9 is a homodimer in solution, and EM studies, with UL9
bound to oriS, indicate the existence of a dimer or pair of dimers
assembled on oriS (7). Several reports indicate that UL9 can
physically interact not only with ICP8 (8) but also with other
members of the HSV-1 replication complex, including UL8 (9)
and UL42 (10). Thus UL9 functions as a docking protein to
recruit these essential replication proteins to the viral origins.
ICP8 stimulates the helicase activity of UL9 (11, 12) and binds
to its C-terminal 27-aa residues (13). In the presence of ICP8,
UL9 will open dsDNA containing Box I, leading to a conforma-
tional change in the origin, thus facilitating unwinding (14–16).
As stated above, the changes in DNA conformation in the com-
plete oriS may be more complex (3). Recently, it has been sug-
gested that single-stranded oriS folds into a unique and evolu-
tionarily conserved conformation, oriS*, which is stably bound
by UL9. oriS* contains a hairpin formed by complementary
base pairing between Box I and Box III in oriS (17). UL9, in the
presence of the single-stranded DNA-binding protein ICP8,
can convert an 80-bp double-stranded minimal oriS fragment
to oriS* and form a UL9-oriS* complex. The formation of a
UL9-oriS* complex requires ATP hydrolysis (18). Therefore,
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the UL9-oriS* complex may serve as an assembly site for the
herpesvirus replisome. Macao et al. (3) proposed a model in
which full-length UL9 would be required to adopt a different
conformation when binding to oriS or oriS*. The implication is
that UL9 partially unwinds and introduces a hairpin into the
origin of replication and that the formation of oriS* is aided, in
some way, by ICP8 and requires ATP hydrolysis. Macao et al.
(3) suggest that the length of the single-stranded tail of the
probe DNA determines the stoichiometry of the UL9-DNA
complex. oriS may bind two molecules of UL9, whereas oriS*
may only bind one because the hairpin formation prevents the
second interaction.
Photo-cross-linking studies have shown that, although the
UL9 protein binds Box I as a dimer, only one of the two mono-
mers contacts Box I, suggesting that the C terminus of UL9
undergoes a conformational change upon binding to Box I (19).
The results reported here are consistent with this observation.
To date there is no three-dimensional structural information
available on the full-length UL9 or either of the functionally
characterized (helicase andDNAbinding) domains. The ability
to adopt different conformations and a tendency to proteolytic
degradationmay be responsible for this. It has been shown that
UL9 binds with very high specificity to the Box I through its
DNA-binding domain, consisting of the C-terminal 317 aa
(UL9ct) (20, 21). Although the importance of the binding
between UL9ct and oriS for the viral life cycle is well estab-
lished, the mechanism behind this interaction still remains
unclear. Even though UL9ct exists as a monomer in solution,
uncertainty remains as towhether one or twomolecules bind to
a single Box I recognition sequence. Some reports have sug-
gested that one UL9ct molecule binds to a single copy of the
sequence (22–24), whereas others have proposed that UL9ct
forms a dimer when bound to DNA (25, 26). This apparent
differencemaywell result from the different protein concentra-
tions used in different assays/experiments, which in turn high-
lights the difficulty of translating in vitro equilibrium experi-
ments into cellular nonequilibrium situations.
A few years ago, the crystal structure of a 60-residue C-ter-
minal deletionmutant of ICP8 (ICP8C)was determined to 3Å
resolution (ProteinData Bank code 1URJ (27)). The structure of
ICP8C consists of a largeN-terminal domain (aa 9–1038) and
a smaller entirely helical C-terminal domain (aa 1049–1120)
connected to the N-terminal domain by a disordered linker (aa
1038–1049) spanning around 18 Å in the crystal structure.
ICP8 preferentially binds ssDNA over dsDNA in a nonse-
quence-specific and cooperative manner (28). ICP8 is a zinc
metalloprotein containing one zinc atom per molecule, which
is coordinated by three cysteines (Cys-499, Cys-502, and Cys-
510) and a histidine (His-512) (27).
In this study, we show that the 60-amino acid C-terminal
deletion of ICP8 (ICP8C) binds strongly toUL9ct.We present
three low resolution structures in solution using small angle
x-ray scattering as follows: that of the UL9ct alone, in complex
with ICP8C, and in complex with a 15-mer dsDNA
(dsDNA15-mer) containing the Box I sequence. Using these data
and a variety of biophysical techniques, we demonstrate that
the stoichiometries of the UL9ct-dsDNA15-mer and UL9ct-
ICP8C-dsDNA15-mer complexes are 2:1 and 2:1:1, respec-
tively, at the micromolar protein concentrations used in this
study. Using EM we visualize the assembly of the ICP8C-
UL9ct complex on oriS and estimate the size of the complex.
EXPERIMENTAL PROCEDURES
Materials—Insect-cell culture media and reagents were
obtained from Invitrogen, and the oligonucleotides were from
MWG and Eurogentec. Escherichia coli BL21(DE3)pLysS cells
and the pET-23b plasmid were obtained from Novagen.
Expression and Purification of Native and Mutant UL9ct
Proteins—TheUL9ct clone was a kind gift of Dr. N. Stow (MRC
Virology Unit, Glasgow, Scotland, UK) (29). A single colony of
E. coli strain BL21(DE3)pLysS transformed with the appropri-
ate plasmid was inoculated overnight at 30 °C in 5 ml of LB
medium supplemented with 50 g ml1 ampicillin and 34 g
ml1 chloramphenicol. Oneml of culture was used to inoculate
1 liter of LB medium supplemented with the same antibiotics.
For the native protein, after growing at 30 °C to A600  0.8, the
culturewas rapidly cooled to 15 °C, and expressionwas induced
with 1 mM isopropyl -D-thiogalactopyranoside. Harvesting
took place after 12–14 h of expression at 15 °C. Finally, the cells
were harvested by centrifugation at 11,500  g, and the pellets
were stored at 20 °C until required.
A pellet from 1 liter of cells was resuspended in 30 ml of
buffer-L1 (20mMHEPES-NaOH, pH 8.0, 100mMNaCl, 0.5mM
EDTA, 1 mM dithiothreitol, and 10% (v/v) glycerol). The cells
were sonicated, and the supernatantwas separated from the cell
debris by centrifugation at 64,000  g (Beckman SA-300 rotor)
for 1 h at 4 °C. The proteinwas purified over an SP-Sepharose (1
ml) column followed by a heparin (1 ml) column. In each case,
once the base line had been reached, a linear gradient from 100
to 1000 mM NaCl in buffer-L1 was used to elute the protein. A
final purification step using size exclusion chromatographywas
carried out using a Superdex-75 (10/30) column. The UL9ct
concentrationwas estimated from the theoreticalmolar extinc-
tion coefficient at 280 nm (38,305 M1 cm1).
Insect Cell Expression and Purification of ICP8C—ex-
presSF insect cells (Protein Sciences Corp.) were maintained
in Sf900II medium supplemented with 100 units ml1 penicil-
lin/streptomycin (Invitrogen) and grown in 2.5-liter suspension
flasks (Fernbach) to a cell density of 4  106 cells ml1. Cells
were diluted 1:2 prior to infection with the recombinant bacu-
lovirus at a multiplicity of infection of 5. Sixty five to 70 h after
infection, cells were harvested, washed twice in cold phos-
phate-buffered saline, and frozen at 80 °C.
The insect cell pellets from 300 ml of insect cell culture were
resuspended in 50 ml of lysis buffer-L2 (50 mM Tris-HCl, pH
8.0, 150 mMNaCl, 1 g ml1 DNase I, and 4 tablets of protease
inhibitor mixture (Roche Applied Science)) and homogenized
by sonication. The lysed cells were cleared by centrifugation at
64,000  g for 1 h in a Beckman SA-300 rotor. The protein
solution was applied to a 5-ml nickel-chelating column fol-
lowed by a gel filtration column (Superdex-200) using an Äkta
purifier (Amersham Biosciences) equipped with the three-di-
mensional kit. The His6-tagged protein constructs were puri-
fied following a standard three-dimensional Äkta purifier pro-
tocol with a combined low imidazole (5 mM imidazole) and a
high salt (500mMNaCl) washing step. The proteinswere eluted
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from the nickel-chelating column with buffer-L2  500 mM
imidazole. The final gel filtration and storage buffer was buff-
er-GF (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 5% (v/v)
glycerol).
Formation and Purification of the ICP8C-UL9ct Complex—
The UL9ct-ICP8C complex was purified using one of two
strategies as follows: 1) either by mixing the separately purified
proteins together in the appropriate molar ratio and running
the mixture through a gel filtration (Superdex-200) column, or
2) bymixing the corresponding cell lysates together and follow-
ing a three-dimensional kit protocol (Amersham Biosciences)
with a nickel-chelating column followed by size exclusion chro-
matography. The nature of the complex did not depend on the
manner of preparation (note that only ICP8C is His6-tagged).
Formation and Purification of the 15-mer dsDNA Template
and theBinary andTernaryComplexes—Two15-base-long oli-
gonucleotides were purchased to form the dsDNA15-mer, the
F15-mer 5-gcgttcgcacttcgt-3 and the R15-mer 5-acgaagtgc-
gaacgc-3. Equimolar amounts of the complementary oligonu-
cleotides were mixed, heated to 90 °C for 20 min in annealing
buffer-A (10 mM Tris-HCl, pH 8.0, 10 mM MgCl2, and 150 mM
NaCl), and cooled slowly to 4 °C overnight to achieve complete
annealing. The duplex DNA was separated from un-annealed
ssDNA using size exclusion chromatography (Superdex-75).
The DNA concentration was calculated based on the reduced
molar extinction coefficient (230,000 M1cm1) calculated by
summing the nucleoside extinction coefficients at 260 nm
and subtracting 18% to correct for the hypochromic effect in
the duplex. In the case of hexachlorofluorescein-labeled
dsDNA15-mer (hex-dsDNA15-mer), the contribution of the fluo-
rescent tag, at 260 nm, was also taken into account (10%).
To test complex formation using EMSA, different molar
ratios of the dsDNA15-mer template and the pre-purified UL9ct
(see above) were mixed and incubated for 30 min at 4 °C in
buffer-GF. The ternary complex was investigated in a similar
manner. For the SAXS experiments on theUL9ct-dsDNA15-mer
complex, a 2:1 molar ratio was used, followed by a polishing
step using a gel filtration column (Superdex-200) to separate
the protein-DNA complex from any unbound dsDNA.
Isothermal Titration Calorimetry—UL9ct and the DNA
duplex were prepared and purified as described above. During
this experiment, buffer-A1 (20 mM HEPES-NaOH, pH 8.0, 100
mM NaCl, 10% (v/v) glycerol) was used, instead of annealing
buffer-A. The 1-ml fractions, corresponding to dsDNA, were
stored at20 °C. ITCmeasurements were carried out in dupli-
cate on aMicroCal VP-ITC instrument at 25 °C. DNA (463M)
was injected into 1.8 ml of buffer-A1 containing UL9ct (15.8
M). The volume of DNA per injection was 2.5 l. The UL9ct
and DNA concentrations were determined as described above.
The kcal/mol per injection was fitted by a two-step reaction
using the Origin software (MicroCal), after subtracting 0.9
kcal/mol, corresponding to the approximate average of the
control experiment, namely titrating buffer without DNA into
the UL9ct solution.
Analytical Size Exclusion Chromatography of the Binary and
Ternary Complexes—Hex-dsDNA15-mer (final concentration 3
M) was incubated with ICP8C (1:1 molar ratio) and with
ICP8C and UL9ct (1:1:1 molar ratio). In this case, the buffer
used was 20 mM HEPES-NaOH, pH 8.0, 100 mM NaCl, 1 mM
EDTA, 10% (v/v) glycerol, and 1mM dithiothreitol. The elution
was performed on a Superose 6 HR 10/30 column. A second
experiment was performed on the native UL9ct-dsDNA15-mer
complex at two protein:DNA ratios (i.e. 1:1 and 2:1) and a final
DNA concentration of 5M. This analysis was performed using
a Superose 12 10/300GL column, run at 1mlmin1 and 4 °C on
an Äkta purifier system. The column was equilibrated with 2
column volumes of buffer-GF. The nucleoprotein complexes
and free DNA were loaded onto the column in 250-l aliquots,
following its calibration with high molecular weight markers
(Amersham Biosciences).
Sedimentation Velocity of the UL9ct-DNA Complex—Native
UL9ct wasmixed with dsDNA15-mer at 4:1 monomer protein to
DNA ratio at 2.4 M final DNA concentration. Complex (400
l) and buffer (425 l) were loaded into a standard double-
sector EPON cell with quartz glass window assemblies of
12-mm optical path length. The cell was subsequently loaded
into an AN50-Ti analytical rotor and transferred to the centri-
fuge, where it was left to equilibrate at 4 °C. The rotor was
accelerated to 42,000 rpm, and scanswere taken every 10min at
262 nm until complete depletion of sample at themeniscus was
observed. The data produced were analyzed using the c(s) pro-
grampresent in theUltraScan 7.1 software package. The partial
specific volume (VP) used for the analysis of the complex data
(0.71ml g1) was calculated based on Equation 1 that takes into
account the individual VP values of UL9ct (0.73 ml g1, calcu-
lated by SEDNTERP (30)) and DNA (0.55 ml g1 (31)), and the






where VP(PnD) is the partial specific volume of the nucleopro-
tein complex; n is the number of proteinmonomers;VP(P) is the
partial specific volume of UL9ct;MP is the molecular weight of
UL9ct; VP(D) is the partial specific volume of DNA; and MD is
the molecular weight of the DNA used.
EMSA—Different molar ratios of protein in buffer-GF were
mixed with equal volumes of the dsDNA15-mer, containing the
Box I UL9 recognition site (annealed F15-mer 5-gcgttcgcact-
tcgt-3 and R15-mer 5-acgaagtgcgaacgc-3). The binding reac-
tions, typically 30–40 l, were left to equilibrate at 4 °C for 30
min before loading onto a 1.0% TBE-agarose gel in 0.5 TBE
buffer. Following electrophoresis at 8 V cm1 for 3 h, DNAwas
visualized with ethidium bromide, and the proteins were visu-
alized with Coomassie Brilliant Blue staining.
ElectronMicroscopy on the Complexes of UL9ct-ICP8Cwith
the Herpes Simplex Virus Type 1 Origin Containing DNA (oriS)—
In a typical reaction (50l) pGEM822 plasmid DNA (33) or the
822-bp HSV-1 BamHI fragment containing oriS isolated from
pGEM822 was mixed with the 1:1 UL9ct-ICP8C complex in
binding buffer (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM
MgCl2, and 1 mM dithiothreitol) to give final concentrations of
3 g ml1 of DNA (150–250 ng) and 45 g ml1 of protein
(2.25g). Themixturewas incubated for 1 h at 37 °C, then fixed
with 0.6% glutaraldehyde (final concentration) for 5 min, and
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chromatographed over 2-ml columns of 10% agarose beads
(Agarose Bead Technology, Colna, Portugal) to remove free
protein and fixatives. The fractions containing DNA-protein
complexes were collected, mixedwith spermidine (2.5mM final
concentration), adsorbed onto glow-charged thin carbon foils,
dehydrated through a water-ethanol series, and rotary shadow-
cast with tungsten (34). The samples were examined using a
Tecnai 12 instrument at 40 kV or Philips CM12 instrument at
80 kV. Images were recorded on SO-163 film (Eastman-Kodak
Co.) at magnifications of 35,000, 45,000, or 60,000, and the
images were scanned with an Imacon 848 film scanner (Hassel-
blad A/S, Gothenburg, Sweden). The contrast was optimized,
and images were arranged using Adobe Photoshop software.
The molecular mass of UL9ct-ICP8C complexes bound to
oriS was evaluated as described previously (35). In brief, 1:1
complexes of UL9ct-ICP8Cwere formed on a linear fragment
containing oriS, and following fixation and just prior tomount-
ing, apoferritin (Sigma) (443 kDa) was added. In micrographs,
the projected area of several apoferritin particles was deter-
mined, averaged, and compared with the projected area of the
oriS-DNA complex. Conversion to volume ratios was carried
out on the assumption that the apoferritin and oriS-DNA com-
plexes were spherical, and this was converted to a mass ratio.
The mass of the duplex DNAwithin the complex was excluded
from consideration based on the assumption that it does not
significantly affect the net volume of the complex.
Small Angle X-ray Scattering Measurements—The synchro-
tron radiation x-ray scattering data were collected on the X33
beamline of the EMBL on the storage ring DORIS III (DESY,
Hamburg, Germany) (36). Solutions of UL9ct protein and its
complexes with ICP8C protein (UL9ct/ICP8C) and
dsDNA15-mer (UL9ct/DNA) were measured at 15 °C in the sol-
ute concentration range between 0.8 and 1.5mgml1 in buffer-
GF. The data were recorded using aMAR345 two-dimensional
image plate detector at a sample-detector distance of 2.7 m and
a wavelength of   1.5 Å, covering the range of momentum
transfer 0.12 
 s 
 4.5 nm1 (s  4 sin/, where 2 is the
scattering angle). To check for radiation damage, the data were
collected in two 2-min exposures. These measurements indi-
cated no changes in the scattering patterns with time, i.e. there
was no measurable radiation damage. The data were averaged
after normalization to the intensity of the incident beam, and
the scattering of the buffer was subtracted. All data manipula-
tionswere performedusing the programpackage PRIMUS (37).
The forward scattering I(0) and the radius of gyration (Rg)
were evaluated using theGuinier approximation assuming that,
at very small angles (s 
 1.3/Rg), the intensity is represented as
I(s) I(0) exp((sRg)2/3). These parameters and themaximum
diameter (Dmax) of the particle were also computed from the
entire scattering patterns using the program GNOM (38).
The excluded volume, Vp, of the particle was computed from
the Porod invariant (39). The molecular masses of the solutes
were evaluated by comparison of the forward scattering with that
from reference solutions of bovine serum albumin (66 kDa).
The ab initio low resolution shape analysis of UL9ct was per-
formed using the programDAMMIN (40). The program repre-
sents the molecule as a collection of M  1 densely packed
beads inside a spherewithDmax. Each bead belongs either to the
molecule or to the solvent, and the shape is described by a
binary string of length M. Starting from a random string, sim-
ulated annealing is employed to search for a compact model
that fits the shape of the scattering curve I(s) to minimize the










whereN is the number of experimental points; c is a scale factor,
and Icalc(sj) and (sj) are the calculated intensity and the exper-
imental error at the momentum transfer sj, respectively. The
program GASBOR (41) was used to create ab initio models of
the UL9ct protein consisting of dummy residues instead of
beads. In this program a simulated annealing protocol is
employed to construct a model with a protein-like distribution
of beads that provides the best fit to the experimental data. For
all ab initio analyses,multiple runswere performed to verify the
stability and reliability of the solution.
The structure of the ICP8C-UL9ct complex (with 1:1 stoi-
chiometry) was refined by rigid body modeling using the pro-
gram SASREF (42), which employs a simulated annealing pro-
tocol to generate an interconnected assembly of subunits
without steric clashes fitting the scattering data. Themonomer
model of ICP8C was taken from the crystal structure (27),
whereas for UL9ct, the reconstructed ab initio envelope was
used. The scattering amplitudes from the two proteins were
calculated using the program CRYSOL (43). Two potential
models were found by multiple runs of SASREF. Cross-linking
results (see supplemental material) would marginally favor one
of these models.
The ab initio model of the UL9ct-DNA complex was per-
formed by a multiphase bead modeling programMONSA (44).
This program describes the model by an assembly of beads
inside a spherical search volumewith the diameter equal to that
of the complex. Simulated annealing is employed to find which
bead belongs to which part of the complex (protein or DNA) by
simultaneous fitting of two scattering curves (from the UL9ct-
DNA complex and the theoretical dsDNA scattering alone).
Several independent runs yielded reproducible models of
UL9ct/DNA (with a 2:1 stoichiometry), which produced good
fits to the experimental scattering profiles.
RESULTS
UL9ct Is a Monomeric Globular Protein
The experimental SAXS curves from the UL9ct protein are
displayed in Fig. 1A, and the overall parameters computed from
the data are presented in Table 1. The molecular mass of the
UL9ct protein at the concentration 0.8 mg ml1 is 38  5 kDa,
as estimated from the relative forward scattering intensity (s 
0), suggests that the protein is monomeric in solution, as
expected at low concentration. This finding is further corrobo-
rated by the excluded (Porod) volume of the particle in solution
of (78  5)  103 Å3 using the empirical finding that for glob-
ular proteins the hydrated volume in Å3 should numerically be
about twice the molecular mass in daltons. The ab initiomodel
for UL9ct as derived from an average of 10 GASBOR runs is
HSV-1 Origin Assembly
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shown in Fig. 1B. The discrepancy factor for the fits, 	, was 1.65.
It is apparent that after some hours UL9ct tends to irreversibly
dimerize, and the ab initio envelope of the dimer restored by
DAMMIN (	  1.97) is also shown in Fig. 1C. This time-de-
pendent dimerization has required the use of freshly prepared
protein and to consider the effects (especially at higher temper-
atures) of producing nonproductive material, with possible
effects on the apparent stoichiometry.
UL9ct Forms a Stable 1:1 Complex
with a 60-Amino Acid
C-terminal Deletion of ICP8
High levels of UL9ct expression
were attainable using the E. coli
BL21(DE3)pLysS strain. ICP8C
was expressed in insect cells as an
N-terminal His6-tagged protein,
which was then used to pull down
UL9ct. The most efficient means of
ICP8C-UL9ct complex formation
was by mixing the UL9ct cell lysate
with the ICP8C cell lysate and
using the Äkta three-dimensional
purification kit with a two-column
strategy (nickel-chelating and size
exclusion), as described under
“Experimental Procedures.”
The UL9ct-ICP8C complex
includes 354  1160 amino acids
with an actual molecular mass of
161 kDa. The complex eluted as a
single peak with an apparentmolec-
ular size of 170 kDa, based on the
logarithmofmolecularmass against
protein standards that had been
passed through the same column
(data not shown). This finding sug-
gested that the complex exists as a
1:1 heterodimer in solution, as
reported previously. However,
because the behavior of a protein
during chromatography on a gel fil-
tration column correlates directly
with its Stokes radius andnot always
with its true molecular weight,
other methods of determining the
stoichiometry of the complex were
also employed (see below).
At high concentrations (above 1.8 mg ml1) UL9ct starts to
aggregate and precipitate, even at 4 °C. The addition of ICP8C
to UL9ct greatly stabilizes UL9ct even at higher concentrations
(above 10 mgml1), and no precipitation or degradation of the
complex was observed.
For the SAXSmodel of the ICP8C-UL9ct complex, the esti-
mated molecular mass of the UL9ct-ICP8C complex (at 1.1
mg ml1) is 140  10 kDa, which is compatible with a 1:1 ratio
for the complex. The excluded volume of the complex (310 
10)  103 Å3 is also in good agreement with 1:1 stoichiometry.
Two potential models for the UL9ct-ICP8C complex, as
obtained using SASREF, and shown in Fig. 1, D and E, gave
almost identical fits to the scattering data (	  1.41). Chemical
cross-linking results (supplemental material) would slightly
favor the model in Fig. 1E. The partial obstruction of the
assumed (27) ssDNA-binding region of ICP8C (in yellow in
Fig. 1,D andE) byUL9ct is common to bothmodels. This result
implies that the complex will not bind to ssDNA, unless it first
FIGURE 1. A, solution scattering curves (dots with error bars) for the UL9ct monomer (lower) and the UL9ct-
ICP8C complex (upper) together with the calculated curves for the models shown in B and E. B, molecular
envelope of the UL9ct monomer as determined from solution scattering experiments with approximate
dimensions. The two views are rotated with respect to each other by a 90° rotation about the vertical axis.
C, envelope of the UL9ct dimer, which forms over time. D and E, two possible models of the UL9ct-ICP8C
binary complex derived from the x-ray scattering data using the known structure of ICP8C and the envelope
of UL9ct. The UL9ct envelope (spheres about the dummy residues) is shown in green, and a similar representa-
tion of ICP8C is shown in magenta. The two ICP8C domains (the smaller C-terminal helical domain (26) is
seen as a protrusion on the right) were allowed to move independently in each case, constrained by a linker of 10
residues. The expected ssDNA-binding cleft (27) is indicated by a yellow line, indicating that ssDNA binding would be
obstructed if UL9ct is bound. The red circles show the approximate positions of the surface lysines on ICP8C that are
modified by the cross-linker (supplemental material) suggesting a preference for the structure shown in E.
TABLE 1
Parameters of UL9ct and UL9ct-ICP8C and UL9ct-DNA complexes
calculated from the SAXS data
The abbreviations used are as follows: Rg, radius of gyration;Dmax, maximum size of
the particle; VP, excluded volume of the hydrated particle, Experimental mass,
experimental molecular mass of the solute.
Samples Concentration Rg Dmax VP
Experimental
mass
mg/ml nm nm nm3 kDa
UL9ct 0.8 2.63  0.04 8.0  0.5 78  5 38  5
UL9ct/ICP8C 1.1 4.55  0.06 16.0  1.0 310  10 140  10
UL9ct/DNA 1.5 3.57  0.05 12.5  1.0 145  10 78  10
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dissociates, whereupon ICP8C alone will bind. We examined
electron micrographs (supplemental material) of the UL9ct-
ICP8C complex incubated with ssDNA for times between 5
and 30 min. The micrographs showed longer continuous
ICP8C (only) covered tracts with time but were otherwise
difficult to quantify.
At Micromolar Protein Concentrations, UL9ct and
a dsDNA15-mer Containing the Box I Sequence Form
a 2:1 Complex
SAXS Model of the UL9ct-DNA Complex—The analysis of
the scattering curves (Fig. 2A) of the UL9ct-dsDNA15-mer com-
plex (18 M), using the program MONSA, which uses the
experimental scattering curve of the complex together with the
theoretical scattering for a 15-mer dsDNA, provides a low res-
olution structure of the complex (Fig. 2B) suggesting a 2:1 stoi-
chiometry (the discrepancy factor for the fit 	  1.58). This is in
agreement with the estimated excluded volume of UL9ct/
dsDNA (145  10  103 Å3). The structure makes two impor-
tant statements. First, the two UL9ct molecules in the complex
are not identical in shape, and second, one UL9ct apparently
either surrounds, or almost surrounds, the dsDNA. This agrees
with previous work (19) based on cross-linking studies suggest-
ing that the second UL9ct molecule does not contact the DNA.
The 2:1 UL9ct-DNA complex is less extended than the dimer
model of UL9ct (Fig. 1C).
Sedimentation Velocity of the UL9ct-DNA Complex—Al-
though size exclusion chromatography is often used to estimate
themolecular weights of proteins, the results can bemislead-
ing if the molecules are not entirely globular. A discrepancy
is even more likely for DNA and protein-DNA complexes. In
contrast, analytical ultracentrifugation is an absolute tech-
nique capable of directly measuring the sedimentation coef-
ficient (s), diffusion coefficient (D), and the molecular mass
of macromolecules, with no assumptions required as to their
shape. Sedimentation velocity was therefore employed to
examine the UL9ct-DNA complex. The experiment was per-
formed at a 4:1 protein:DNA ratio (final DNA concentration
of 2.4 M). The absorbance was measured at 262 nm. The
data were analyzed using the c(s) program included in the
UltraScan 7.1 software (Fig. 3). The results show that UL9ct
forms a dimer when bound to its recognition sequence,
because almost 80% of the species sediments at 2.80 S with an
estimated molecular mass of 79 kDa (compared with the
predicted molecular mass of a 2:1 protein-DNA complex of
81 kDa). A smaller component (14%) at 1.77 S is most
probably free protein because its molecular mass is 37.8 kDa,
which compares favorably with the theoretical value for a
monomer (36 kDa), rather than that for a monomer protein-
DNA complex (45 kDa). Although there was a 2-fold
excess of protein in this experiment, its absorption at 262 nm
is very much less than that of DNA.
From these data, the frictional ratio of the free protein and
the nucleoprotein complex can be obtained (f/f0  1.90 and
2.17, respectively, after allowing for hydration). This indicates
that UL9ct is a somewhat elongated protein, and the complex
even more elongated, consistent with the SAXS results (Fig. 1B
and Fig. 4B).
Isothermal Titration Calorimetric Analysis of the UL9ct
Binding to Box IDNA—The exothermic reaction could be fitted
(Fig. 4) by a two-step reaction,with thermodynamic parameters
given in Table 2. In electrophoretic mobility shift assays, inter-
mediate species were never observed. This may be explained if
the second reaction has a lowerKd value than the first, which in
turn implies that a (conformational) change occurs upon initial
binding and that this enhances the affinity for the second bind-
ing event. Because the Box I DNA was injected into the UL9ct
solution, it is expected for 2:1 UL9ct/DNA stoichiometry that
the number of sites would be 0.5. The determined value of 0.33
implies either errors in the estimated concentrations of protein
and DNA (which are not expected to be more than 10%) or a
proportion of inactive UL9ct resulting from nonproductive
dimerization at the temperature used, or both. We also inves-
tigated the binding of two UL9ct mutants, K746A and K758A,
to the dsDNA15-mer by EMSA (supplemental material), which
could also be analyzed in terms of a two-step model.
FIGURE 2. A, scattering curve for the UL9ct-dsDNA complex (dots with errors
bars) with MONSA (blue solid curve) and SASREF fits (red dashed curve). B, ab
initio MONSA envelope for the 2:1 UL9ct-dsDNA15-mer complex in two orien-
tations related to each other by a vertical rotation of 90°. The protein is col-
ored green and the DNA colored brown.
HSV-1 Origin Assembly
16348 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284 • NUMBER 24 • JUNE 12, 2009
At Micromolar Protein Concentrations, UL9ct, ICP8C, and the
Box I-containing DNA Form a 2:1:1 Complex
Analytical Size Exclusion Chromatography of the Ternary
Complex—The dsDNA15-mer used containing the Box I recog-
nition sequence for UL9 located within the HSV-1 oriS was
5-hexachlorofluorescein-labeled on the forward strand. The
final concentration was 3 M. During gel filtration chromatog-
raphy, only the hexachlorofluorescein-labeled DNA was
observed (540 nm). A 1:1:1UL9ct:ICP8C:dsDNAmixturewas
used, so as to observe whether the three macromolecules form
a ternary complex in solution or not. Buffer GF (50 mM Tris-
HCl, pH 8.0, 150mMNaCl, and 5% (v/v) glycerol) was usedwith
a Superose 6 HR 10/30 gel filtration column. No attempt was
made, at least in part, to translate the elution volumes obtained
from the two gel filtration runs to molecular mass because the
presence of DNA would anyway tend to yield elongated rather
than globular shapes. The only peak observed for the 1:1
ICP8C:DNAmixture at 540 nm (Fig. 5A,mauve curve) corre-
sponds to free DNA, and thus no ICP8C-DNA complex is
formed in solution, consistent with the EMSA result (see
below). For the 1:1:1 UL9ct:ICP8C:DNAmixture, three peaks
were observed (Fig. 5A, blue curve). Subsequent 10% native
PAGEanalysis of the peak fractions suggested that the first peak
corresponds to the ternary complex, the second peak corre-
sponds to the UL9ct-DNA complex, and the third peak to free
DNA (see the supplementalmaterial). In a separate experiment,
in a different buffer (Fig. 5B), the elution profiles monitored at
256 nm for free DNA (green), a 2:1 UL9ct:DNA mixture (pink)
and a 1:1 UL9ct-DNA mixture (blue) confirm the 2:1 stoichi-
ometry of the UL9ct-DNA complex.
FIGURE 3. Sedimentation velocity analysis. A, distribution of sedimentation
coefficients c(s). B, distribution of molecular weights c(Mr) for the 4:1 molar
mixture of UL9ct and the dsDNA15-mer. The analysis shows three species as
follows: UL9ct (37.8 kDa, s20,w  1.77 S, D20,w  4.06  10
7 cm2 s1; % of
mixture  13.8), 2UL9ct:DNA (78.3 kDa, s20,w  2.80 S. D20,w  3.22  10
7
cm2 s1, % of mixture  78.8)- and a higher molecular weight species (108.6
kDa; s20,w  3.57S, D20,w  2.85  10 
7 cm2 s1, % of mixture  7.4), which
can be interpreted as a 3:1 UL9ct-DNA complex.
FIGURE 4. Isothermal titration microcalorimetric analysis of the Box
I-containing dsDNA15-mer to UL9ct. A, trace of the calorimetric titration of
30  2.5-l aliquots of 463 M DNA injected into 1.8 ml of 15.8 M UL9ct.
B, solid line in the lower plot represents the best fit to the data given by the
parameters in Table 2.
TABLE 2
Thermodynamic parameters for Box I dsDNA-UL9ct binding derived
from the isothermal microcalorimetric titration
First binding event Second binding event
Kd (nM ) 6.2  2.5 0.81  0.33
H (kcal/mol) 13.6  1.1 1.69  1.0
S (cal/mol/K) 8 48
No. of sites 0.32  0.01 0.33  0.01
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Gel Retardation Studies on the Binding of UL9ct and ICP8C
to a 15-mer dsDNA Template—The formation of the ternary
complex was studied by EMSA, to elucidate the stoichiometric
ratio of the interaction, again with proteins in the micromolar
concentration range. Different combinations of UL9ct-
ICP8C-DNA were tested by 0.8% (w/v) agarose gel electro-
phoresis and are presented in Fig. 6. The gels were run for 60
min at 80 V and at 20 °C. The starting DNA concentration for
all experiments was 3.33 M. Based on the results presented in
Fig. 6, the following conclusions can be drawn. ICP8C does
not interact with the dsDNA molecule used for these assays
(Fig. 6, A and B, lane 5). UL9ct interacts with the particular
dsDNA at the stoichiometric ratio of 2:1 (Fig. 6, A and B, lanes
2–4, and C and D, lanes 2 and 3). The UL9ct-ICP8C-DNA
complex (Fig. 6, A and B, lanes 6–8, and C and D, lanes 4–6)
gives rise to a single band at the ratio of 2:1:1. Therefore, this
ratio probably describes best the ternary complex interaction at
these protein concentrations.
The ratio of shifted duplex DNA was measured by either a
preincubation of UL9ct with the dsDNA15-mer and then addi-
tion of ICP8C (Fig. 6, A and B), or with a preincubation of
UL9ct with ICP8C and then addition of dsDNA15-mer (Fig. 6,
C andD). Upon preincubation of UL9ct with the duplex-DNA,
the ternary complex formation may be less stable or less effi-
cient (compare Fig. 6, B, lane 7, with D, lane 5).
Binding of UL9ct-ICP8C Complexes to Herpes Simplex
Virus Type 1 Origin Containing DNA (oriS)—The binding of
the UL9ct-ICP8C complex to oriS present on either super-
twisted pGEM822 plasmid DNA or on the 822-bp HSV-1
BamHI fragment was examined by EM. The complexes were
formed by incubating theseDNAswith a 1:1 complex of UL9ct-
ICP8C for 1 h at 37 °C followed by preparation for EM. Exam-
ination of fields of DNA-protein complexes revealed that the
binding of UL9ct/ICP8C to dsDNA is highly efficient. With
the super-twisted template (Fig. 7, A and B), 43% (n  121) of
the DNA had no protein bound, 57% showed one complex, and
no DNAs were observed with two or more complexes bound,
arguing for a very low level of nonspecific binding. This is a
significantly higher specificity (50%) than in previous studies
(16) where the full-length UL9 and ICP8 proteins were incu-
bated with the same DNA template. There, a background of
nonspecific binding was observed, possibly due to the binding
of the full-length proteins to sites on the super-twisted DNA-
containing single-stranded character.
To further illustrate the specific binding ofUL9ct/ICP8C to
oriS, the 822-bp fragment in which oriS is located one-third the
distance from the nearest end was incubated with UL9ct/
ICP8C and prepared for EM. Examination of fields of these
complexes (Fig. 7, C and D) revealed that 22% (n  137) of the
DNAs were bound by a single large protein complex at a site
one-third the distance from one end, and only 3% showed pro-
tein bound at sites not consistent with oriS. The remaining 75%
of the DNA appeared protein-free. When super-twisted or lin-
ear DNAs lacking oriS were incubated with UL9ct/ICP8C in
parallel with the experiments above, less than 4% (n  124 and
156, respectively) of the DNAs showed any large protein com-
plexes bound. The complexes bound to both the super-twisted
and linear templates were homogeneous in size and shape sug-
gesting that evaluation of their mass would prove useful.
The mass of the protein complexes bound at oriS was evalu-
ated using internal mass standards as described previously (37).
Apoferritin, which is roughly spherical in shape and has a mass
of 443 kDa, was selected as amass standard. For thesemeasure-
ments, complexes of UL9ct-ICP8C were formed on the
822-bp oriS fragment; the complexes fixed in place, and then
just prior to mounting for EM, apoferritin was added. The pro-
jected areas of the protein complexes on the DNA and apofer-
ritin molecules were determined from the micrographs allow-
ing an estimate of themass of theDNA-protein complexes to be
made. This analysis revealed that the average calculated volume
of theUL9ct-ICP8Ccomplex bound to oriS exceeded an aver-
age volume of apoferritin by 1.78-fold. Thus, the molecular
mass of the UL9ct-ICP8C complexes bound to oriS is esti-
mated to be 790 211 kDa (n 24). The projected areas of the
apoferritin particles varied only by 10% (n 12) suggesting that
theUL9ct-ICP8Ccomplex ismore heterogeneous in size than
the internal marker. The combined mass of a 2:1 UL9ct/
ICP8C is197 kDa, suggesting that around four copies (aver-
age 4.1  1.0) are bound at oriS. This suggestion is speculative
for two reasons. First, the EM images were recorded at protein
concentrations 2 orders of magnitude lower than the in vitro
FIGURE 5. A, analytical gel filtration of the ternary complex using the fluores-
cein-labeled dsDNA15-mer. The chromatogram in mauve is for a 1:1 ICP8C:
DNA mixture where only the DNA is observed, whereas the chromatogram in
blue is for a 1:1:1 UL9ct:ICP8C:DNA mixture. The labels are as follows: a,
ternary ICP8C-UL9ct-DNA complex; b, binary UL9ct-DNA complex; and c,
free DNA. A native page of fractions a– c is given in the supplemental material.
B, gel filtration of UL9ct:DNA mixtures at increasing protein concentration.
Profiles shown are at protein:DNA ratios of 1:1 (blue) and 2:1 (pink) together
with free DNA (green).
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assays, and consequently the ratio of 1:1 and 2:1 UL9ct-DNA
complexeswill differ. Second, an extrapolation of our results on
Box I binding to that on the full oriS is simplistic, in that it does
not address rearrangements in oriS.
DISCUSSION
UL9ct was expressed and purified in high yields, and it was
possible to concentrate the pure protein, without aggregation,
to a concentration of 1.8 mg ml1 (50 M). At higher concen-
trations the protein starts to aggregate and upon prolonged
storage at 4 °C even to precipitate. The initial process is via
dimer formation and a possible physiological importance of
this is discussed below, even though the dimerization of the
full-length protein (UL9) is driven by the N-terminal domain,
which is missing in our construct. The importance of a possible
pseudo-leucine zipper (aa 570–591), which could result in
dimerization (45), is less certain. A consequence, however, is
that UL9ct is a difficult target for crystallization, compounded
by a conformational flexibility suggested by the results pre-
sented in this paper, and we have had no success in extensive
crystallization trials. Consequently,
we decided to investigate the low
resolution structure from freshly
prepared samples using SAXS.
SAXS measurements were per-
formed successfully at concentra-
tions of 0.8 mg ml1 for UL9ct
alone, and at 1.5 mg ml1 for the
complex with a dsDNA15-mer con-
taining the Box I consensus
sequence. The molecular mass of
UL9ct, estimated from the relative
forward scattering intensity, was
38 5 kDa, suggesting that the pro-
tein is monomeric in solution at low
concentration. The low resolution
shape of UL9ct was reconstructed
ab initio using the programs DAM-
MIN and GASBOR. The average of
10 runs of the latter is shown in Fig.
1B. Over a period of time it seems
thatUL9ct dimerizes, but this dimer
is more elongated than that
observed in the UL9ct-DNA com-
plex (compare Fig. 1C and Fig. 4B).
Although UL9ct exists as a mon-
omer in solution at low concentra-
tions, there has been some discus-
sion as to whether one (22–24) or
two (25, 26) molecules bind to a sin-
gle Box I recognition sequence. In
this work, by using a variety of bio-
physical techniques, we show that it
forms a UL9ct-dsDNA 2:1 complex
at micromolar protein concentra-
tions, although the Kd value derived
from the ITC experiments suggests
that a 1:1 complex will predominate
at sub-nanomolar concentrations, consistent with previous
work (22). As mentioned above, UL9ct is monomeric in solu-
tion, but we do observe, in the absence of ICP8C, a tendency
to dimerize. Furthermore, the EMSA and analytical ultracen-
trifugation experiments on the UL9ct/dsDNA show evidence
for the formation of higher molecular weight species, which
could be interpreted as a 3:1 complex, indicative of further
UL9ct-UL9ct interactions.Whether these interactions are spe-
cific or not and whether the resulting complexes are nonpro-
ductive are harder to establish.
ICP8 binds to the extreme C terminus of the full-length UL9
protein and enhances both its helicase and DNA-dependent
ATPase activities (8, 12, 13, 16, 19, 46). Although the mechanism
by which it does so has not been elucidated, removal of the C-ter-
minal 27 aa of the UL9 protein results in loss of the ability to bind
ICP8andenhancedabilityofUL9 tounwinddsDNA in vitro (8, 11,
47). Thus, the C-terminal part of UL9 has been suggested to neg-
atively regulate the activity of UL9, and binding of ICP8 to this
region is proposed to abolish that regulation by masking that
domain and/or by altering the conformationof the protein (19, 47,
FIGURE 6. Binding of UL9ct and UL9ct-ICP8C complex to dsDNA15-mer was analyzed using agarose gel
electrophoresis (1% TBE). We measured the ratio of shifted duplex DNA by either a preincubation of UL9ct
with the duplex DNA (A and B) and then addition of ICP8C, or with a preincubation of UL9ct with ICP8C (C
and D) and then addition of duplex DNA. A and C show ethidium bromide-stained gels, and B and D show the
Coomassie staining of the same gels. S1 corresponds to the binary UL9ct-DNA complex, and S2 corresponds to
the ternary ICP8C-UL9ct-DNA complex.  denotes the presence of one of the components, and  denotes its
absence. 1.5 and 2 indicate the molar ratios of these components in the mixture. Where a number is absent the
molar ratio is unity. Asterisk shows “free” pre-formed 2:1 UL9ct-DNA complex that is not bound to ICP8C.
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48). It has been previously reported (13, 23) that UL9ct and full-
length ICP8 forma complexwith a 1:1 stoichiometry. In this study
we have shown that a 60-aa C-terminal deletion of ICP8 (which
makes the protein less liable to aggregation) also binds very effi-
ciently toUL9ct, suggesting that themissing part of ICP8 does not
play any important role in the interaction of these proteins.
We have determined the low resolution model of an
ICP8C-UL9ct (1:1) complex. Fig. 1,D and E, shows two mod-
els obtained by analysis of the small angle scattering data, using
the (known) crystal structure of ICP8Cand the scattering data
from UL9ct alone and in complex with ICP8C. Because we
cannot distinguish between these models with the SAXS data
alone, we performed cross-linking assays, and although we
were unable to identify any intermolecular cross-linked resi-
dues the work (described in detail in the supplementary mate-
rial) suggests a preference for the SAXS model in Fig. 1E.
For binding of UL9ct/ICP8C to oriS, the interaction
between ICP8 and UL9 is known to depend upon the nature of
the DNA (ss or ds). For example, an ssDNA-oligo(dT)65 com-
pletely prevents full-length ICP8 from binding to a complex
betweenUL9ct and oriS (23). Thismay indicate a preference for
ICP8 to bind to ssDNA or that the ssDNA-binding region of
full-length ICP8 competes with the UL9ct-binding region or
that the ICP8 changes its conformation substantially on bind-
ing to ssDNA such that it is no longer able to bind UL9ct. Our
data support a model whereby an ICP8C-UL9ct complex
increases the ability to bind to another UL9ct molecule already
bound to oriS. It is clear that if twoUL9ctmolecules bind to Box
I of the origin, theymust have different conformations, because
Box I is not a palindrome sequence.We suggest that by binding
to Box I UL9ct undergoes a conformational change that
enhances its affinity for binding to another UL9ct molecule,
perhaps already in complex with ICP8. This hypothesis is con-
sistent with the fact that the EMSA, gel filtration, and analytical
ultracentrifugation results demonstrate a 2:1 UL9ct:DNA stoi-
chiometry at micromolar protein concentrations. The ITC
studies, however, show the existence of a two-step reaction.We
show that the dimeric specieswe observe after lettingUL9ct age
is different (Fig. 2B versus Fig. 1C) from theUL9ct dimer bound
to Box I, further suggesting that binding ofUL9ct to Box I accel-
erates a conformational change, different from nonproductive
dimer formation, which is necessary to form a UL9ct-UL9ct
interaction. Given the measured Kd value, appreciable concen-
trations of a 1:1 complex are expected in equilibriumconditions
at nanomolar concentrations and below (22). It is difficult to
extrapolate this to a cellular context because not only are the
cellular concentrations of UL9 rather uncertain, but given the
localization of the replisome to promyelocytic leukemia-con-
taining regions (49), it is far from certain that in vitro equilib-
rium studies can describe the local environment.
In this study we have chosen to use truncated proteins in
combination with a minimal dsDNA recognition sequence to
have experimentally pure and tractable material. It is therefore
essential to establish whether or not these truncated proteins
assemble on oriS in the same way as the unmodified replication
complex. In a previous study (16) of the binding of full-length
UL9 and ICP8 to oriS, using the same templates used in this
work, similar levels of binding were observed for super-twisted
DNA. 58% of the super-twisted DNA contained one complex
versus 57% in this study. However in the earlier study approxi-
mately one-third of the complexes on super-twisted DNAwere
not localized to oriS. In this study the very low level of binding
to super-coiled DNA lacking oriS (4%) suggests that the level of
nonspecific binding was much lower. The suggestion that the
ICP8C-UL9ct complex has a higher specificity of binding was
reflected in the fact that previously only 14% of the linear frag-
ments containing oriS showed a protein complex assembled at
oriS in contrast to 22% in this study.
It is established from biochemical studies that the minimal
origin complex consists of two UL9 protein dimers bound at
oriS (4, 25, 50, 51). This conclusion was verified in subsequent
EM studies where these origin complexes have been directly
visualized (16, 52). In the previous EM studies when full-length
UL9 and ICP8 proteins were assembled at oriS (16), the size of
the complex suggested that four copies of UL9 and two copies
of ICP8 assemble at oriS.However, with the full-length proteins
therewas a large variation in the size of the bound complex, and
in addition, the efficiency of binding to linear dsDNA was not
high. Here, using the truncated forms of both proteins, we have
found that the assembly of the UL9-ICP8 co-complex is more
efficient, and hence we infer tighter binding. In addition amore
uniform distribution of particle sizes at oriS was observed. This
hasmade it possible to carry out amore precise EM-basedmass
analysis measurement than was possible in the previous work.
The result of our mass analysis of the UL9ct-ICP8C complex
at oriS suggested that there are 3–4 copies of a 2:1 UL9ct-
ICP8C complex, assuming that the binding to a single Box I
sequence involves two molecules of UL9ct and one of ICP8C.
This would fit well with the previous work showing that two
FIGURE 7. ICP8C/UL9ct binding to dsDNA containing the full HSV-1 rep-
lication origin (oriS). ICP8C-UL9ct complex was incubated with either a
super-twisted plasmid pGEM822 (A and B) or BamHI fragment (822 bp) puri-
fied from pGEM822 plasmid containing HSV-1 oriS and prepared for EM anal-
ysis as described under “Experimental Procedures” (C and D). The scale bar
represents 100 nm.
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UL9 dimers are present at oriS in the absence of ICP8, if each
molecule of the conformationally altered UL9 monomer was
able to recruit a UL9-ICP8 complex to the origin.
On the basis of our results, we suggest that the binding of a
UL9molecule to the recognition sequence induces a conforma-
tional change in the C-terminal domain of UL9, which
enhances the recruitment of a second UL9 molecule via an
interaction between C-terminal domains. We thank a referee
for pointing out that this conformational change must also
result in the C-terminal tail of the UL9 molecule, that it is not
interacting with ICP8, thus becoming inaccessible. Given the
affinity of UL9 for ICP8 (also for the truncated proteins used in
this study), this would be a mechanism for recruiting ICP8 to
the origin of replication. Such recruitment is necessary because
ICP8 itself does not have affinity for dsDNAbut only for ssDNA
or ssDNA overhangs of duplex DNA. The N-terminal ATP-de-
pendent helicase function of UL9 can then open the origin,
allowing ICP8 to bind to ssDNA and start its own ATP-inde-
pendent, dsDNA unwinding activity. Recruitment of ICP8 is
probably also important for recruiting the rest of the replication
complex. Finally, we note that our work principally concerns
the proteins bound to duplex Box I and pays scant attention to
the rearrangement of oriS and the possible binding of UL9 to a
DNA hairpin formed from Box I and Box III, which is reported
(3, 17) to form upon activation of the origin, oriS.
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